select a format

Single User License
USD 250 INR 16045
Site License
USD 500 INR 32090
Corporate User License
USD 750 INR 48135

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


ULURU Inc (ULUR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

ULURU Inc (ULUR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH13718D
  • |
  • Pages: 48
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

ULURU Inc (ULURU) is a pharmaceutical company that develops and commercializes wound care and muco-adhesive film products. The company offers products such as Altrazeal, Apthasol, OraDisc W, and others. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU's Apthasol is used for treating aphthous ulcers in people with normal immune systems. The company's OraDisc is a polymer solid dosage form used to deliver amlexanox to the mucosal tissue. It also research and develops Nanoflex technology which is designed for optimizing the wound bed environment and accelerate healing. ULURU is headquartered in Addison, Texas, the US.

ULURU Inc (ULUR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ULURU Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

ULURU Inc, Medical Devices Deals, 2011 to YTD 2017 10

ULURU Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

ULURU Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

ULURU Partners with Saraya 12

Licensing Agreements 12

Uluru Expands Licensing Agreement with Altrazeal 12

Uluru Expands Licensing Agreement With Altrazeal 13

Uluru Expands Licensing Agreement With Altrazeal 14

ULURU Enters Into Licensing Agreement With Melmed Holdings For Altrazeal 14

ULURU Expands Licensing Agreement With Melmed For Altrazeal To Middle East And North Africa 15

ULURU Expands Licensing Agreement With Melmed For Altrazeal 16

Equity Offering 17

Uluru Raises USD5 Million in Private Placement of Shares 17

Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants 18

Uluru to Raise USD1.6 Million in Private Placement of Shares 19

Uluru Completes First Tranche Of Private Placement Of Shares For US$0.09 Million 20

Uluru Completes First Tranche Of Private Placement Of Shares For US$0.4 Million 21

Uluru Increases Size Of Private Placement Of Shares For US$2.4 Million 21

ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million 23

Uluru Completes Private Placement Of Preferred Shares For US$1 Million 24

ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million 25

Debt Offering 27

Uluru Raises USD0.5 Million in Second Tranche of Private Placement of Note 27

Uluru Raises USD0.5 Million in Private Placement of 12.5% Note 28

Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million 28

ULURU Inc-Key Competitors 30

Key Employees 31

Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

Financial Announcements 33

Nov 14, 2016: ULURU Reports Financial Results For Third Quarter 2016 33

Aug 16, 2016: ULURU Reports Financial Results For Second Quarter 2016 35

May 17, 2016: ULURU Reports Financial Results For First Quarter 2016 39

Mar 31, 2016: ULURU Reports Financial Results For Fourth Quarter And Year Ending December 31, 2015 41

Government and Public Interest 44

Feb 22, 2016: ULURU Provides Update On Recent Business Activities-February 2016 44

Other Significant Developments 46

Feb 22, 2016: ULURU Provides Update On Recent Business Activities 46

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Figures

ULURU Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ULURU Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

ULURU Inc, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

ULURU Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ULURU Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ULURU Inc, Deals By Therapy Area, 2011 to YTD 2017 9

ULURU Inc, Medical Devices Deals, 2011 to YTD 2017 10

ULURU Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

ULURU Partners with Saraya 12

Uluru Expands Licensing Agreement with Altrazeal 12

Uluru Expands Licensing Agreement With Altrazeal 13

Uluru Expands Licensing Agreement With Altrazeal 14

ULURU Enters Into Licensing Agreement With Melmed Holdings For Altrazeal 14

ULURU Expands Licensing Agreement With Melmed For Altrazeal To Middle East And North Africa 15

ULURU Expands Licensing Agreement With Melmed For Altrazeal 16

Uluru Raises USD5 Million in Private Placement of Shares 17

Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants 18

Uluru to Raise USD1.6 Million in Private Placement of Shares 19

Uluru Completes First Tranche Of Private Placement Of Shares For US$0.09 Million 20

Uluru Completes First Tranche Of Private Placement Of Shares For US$0.4 Million 21

Uluru Increases Size Of Private Placement Of Shares For US$2.4 Million 21

ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million 23

Uluru Completes Private Placement Of Preferred Shares For US$1 Million 24

ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million 25

Uluru Raises USD0.5 Million in Second Tranche of Private Placement of Note 27

Uluru Raises USD0.5 Million in Private Placement of 12.5% Note 28

Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million 28

ULURU Inc, Key Competitors 30

ULURU Inc, Key Employees 31

ULURU Inc, Subsidiaries 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

ULURU Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com